Segment Information (Tables)

6 Months Ended

Oct. 31, 2015

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The following tables summarize, for the periods indicated, operating results by reportable segment (table in thousands):

	Personalized		Translational
	Oncology		Oncology		Unallocated
	Solutions		Solutions		Corporate
Three Months Ended October 31, 2015	(POS)		(TOS)		Overhead		Consolidated
Net revenue	$	486	$	2,485	$	-	$	2,971
Direct cost of services		(567)		(1,441)		-		(2,008)
Sales and marketing costs		(189)		(620)		-		(809)
Other operating expenses		-		(873)		(1,026)		(1,899)
Stock- based compensation expense (1)		-		-		(748)		(748)

Segment profit (loss)	$	(270)	$	(450)	$	(1,774)	$	(2,493)

	Personalized		Translational
	Oncology		Oncology		Unallocated
	Solutions		Solutions		Corporate
Three Months Ended October 31, 2014	(POS)		(TOS)		Overhead		Consolidated
Net revenue	$	452	$	1,430	$	-	$	1,882
Direct cost of services		(745)		(943)		-		(1,688)
Sales and marketing costs		(423)		(611)		-		(1,034)
Other operating expenses		-		(1,142)		(864)		(2,006)
Stock- based compensation expense (1)		-		-		(820)		(820)

Segment profit (loss)	$	(716)	$	(1,266)	$	(1,684)	$	(3,666)

	Personalized		Translational
	Oncology		Oncology		Unallocated
	Solutions		Solutions		Corporate
Six Months Ended October 31, 2015	(POS)		(TOS)		Overhead		Consolidated
Net revenue	$	971	$	4,822	$	-	$	5,793
Direct cost of services		(1,202)		(3,030)		-		(4,232)
Sales and marketing costs		(521)		(1,197)		-		(1,718)
Other operating expenses		-		(1,806)		(1,904)		(3,710)
Stock- based compensation expense (1)		-		-		(1,523)		(1,523)

Segment profit (loss)	$	(752)	$	(1,211)	$	(5,427)	$	(5,390)

	Personalized		Translational
	Oncology		Oncology		Unallocated
	Solutions		Solutions		Corporate
Six Months Ended October 31, 2014	(POS)		(TOS)		Overhead		Consolidated
Net revenue	$	792	$	3,001	$	-	$	3,793
Direct cost of services		(1,498)		(1,905)		-		(3,403)
Sales and marketing costs		(877)		(1,036)		-		(1,913)
Other operating expenses		-		(2,460)		(1,777)		(4,237)
Stock- based compensation expense (1)		-		-		(1,627)		(1,627)

Segment profit (loss)	$	(1,583)	$	(2,400)	$	(3,404)	$	(7,387)

(1) Stock compensation expense is shown separately and is excluded from direct costs of services, sales and marketing costs, and other operating expenses, as it is managed on a consolidated basis and is not used by management to evaluate the performance of its segments.